Navigation Links
Latest Study Says Statins Don't Slow Alzheimer's

Final answer may depend on outcomes of ongoing clinical trials, expert says

THURSDAY, Jan. 17 (HealthDay News) -- Despite some reports that statins might slow or prevent Alzheimer's disease, a new study finds no evidence for the theory.

While some animal studies have suggested this possibility, whether the same benefit translates to humans hasn't been clear, the researchers said.

"We didn't find a relation between statin use and the risk of Alzheimer's disease or a decline in thinking ability," said lead researcher Dr. Zoe Arvanitakis, an associate professor of neurology at Rush University Medical Center in Chicago.

In addition, brain autopsies found no effect of statins on the two main causes of dementia, Alzheimer's and stroke, Arvanitakis said.

In the study, Arvanitakis' team collected data on 929 Catholic clergy who took part in the Religious Orders Study, which looks at aging and Alzheimer's disease. At the start of the study, all the participants were around 75 years old and had no signs of dementia. All had a brain autopsy after death, and each had yearly cognitive exams for up to 12 years.

The findings were published in the Jan. 16 online edition of Neurology.

When the study started, 119 people were taking statins. Over the 12 years of the study, 191 people developed Alzheimer's. Of these, only 16 had been taking statins.

Moreover, brain autopsies on more than 250 people who died during the study failed to find any evidence that taking statins had an effect on pathology of Alzheimer's disease or strokes, the scientists found.

"This study adds to the growing evidence that statins don't lower the risk of Alzheimer's disease," Arvanitakis said.

However, one expert thinks this study is not conclusive, and clinical trials that are under way should provide a definitive answer on the issue. "We will see the results of these trials fairly soon," said William Thies, vice president of medical and scientific affairs for the Alzheimer's Association.

"This finding fits in with a great deal of other work that has been done on statins," said Thies. "Most of these studies show a benefit, but this is not the first one to show there isn't a benefit."

Statins are excellent drugs for lowering cholesterol, Thies said. "But there is no recommendation that you take statins for Alzheimer's disease," he added.

Larry Sparks, director of the Roberts Laboratory for Neurodegenerative Disease Research at the Sun Health Research Institute in Arizona and one of the first to link statins with Alzheimer's prevention, doesn't think the study was large enough to give a definitive result.

In his own work, Sparks has found a benefit from statins in treating patients with mild to moderate Alzheimer's disease. However, he thinks the type of statin makes a difference.

"Research suggests that statins that don't get into the brain may prevent or slow the progression of Alzheimer's," Sparks said. "This is a continuing story."

More information

For more on Alzheimer's disease, visit the Alzheimer's Association.

SOURCES: Zoe Arvanitakis, M.D., associate professor, neurology, Rush University Medical Center, Chicago; William Thies, Ph.D., vice president, medical and scientific affairs, Alzheimer's Association, Chicago; Larry Sparks, Ph.D., director, Roberts Laboratory for Neurodegenerative Disease Research, Sun Health Research Institute, Sun City, Ariz.; Jan. 16, 2008, Neurology online

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer study finds adolescents dont get same access to latest treatments as younger patients
2. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
3. A Whole New Sandwich Debuts in the Freezer Aisle: LEAN POCKETS(R) Brand Introduces Latest Whole Grain Varieties
4. AST Emergence to Convergence Highlights the Latest High-Risk Organ Donor and Recipient Issues
5. Latest Edition of Ripon Forum Highlights Schwarzeneggers Leadership on Another Challenge Facing his State - Health Care
6. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
7. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
8. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
9. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
10. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
11. PA Governor Rendell Announces Latest Nominations and Appointments
Post Your Comments:
Related Image:
Latest Study Says Statins Don't Slow Alzheimer's
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology: